Elevating Wound Care with SteriPlas Cold Plasma
Elevating Wound Care with SteriPlas Cold Plasma
Our SteriPlas Premium Cold Plasma medical device with powerful microwave argon technology continues to transform chronic wound management with innovative features that make a real difference for patients and healthcare professionals alike.
Here’s what sets the SteriPlas apart:
✅ Pain-Free Application: Gentle yet highly effective, the SteriPlas delivers treatment without discomfort for patients.
✅ Non-Invasive Therapy: No need for surgical interventions or harmful chemicals—just clean, advanced plasma science.
✅ Fast Treatment Times: Delivers powerful results with quick, convenient sessions that fit seamlessly into clinical workflows.
✅ Antibacterial Power: Effectively eliminates all forms of bacteria including superbugs.
By offering a safe, effective, and cutting-edge approach to chronic wound care, the SteriPlas is empowering clinicians to achieve better outcomes for their patients.
Revolutionising global Infection Care
Revolutionizing Wound Care with SteriPlas Premium Cold Plasma
When it comes to chronic wound infections, our SteriPlas Premium Cold Plasma medical device is setting the gold standard in advanced care. Here's why healthcare professionals are choosing SteriPlas:
✅ Dense, Premium-Rich Cold Plasma: Our advanced microwave argon technology generates a superior cold plasma that penetrates deeper and delivers a more powerful therapeutic effect than competitor devices.
✅ Biofilm Breakthrough: Effectively tackles biofilm complications, a leading cause of stalled healing in chronic infections.
✅ Versatility: Proven effective across a wide range of wound types—including diabetic foot ulcers, LVAD infections, burns, and post-surgical wounds.
✅ No Side Effects: Gentle yet powerful, patients experience no adverse reactions.
With SteriPlas, healthcare professionals are redefining what's possible for patients with wounds that resist traditional treatments.
Together, we’re transforming the future of chronic wound care.
Exciting news for SteriPlas activity in Taiwan
Exciting Success for SteriPlas Cold Plasma in Taiwan!
We are proud to share incredible news from our trusted medical distributor, SG Biomedical, who have successfully introduced our SteriPlas Premium Cold Plasma medical device to six leading hospitals across Taiwan. Over 100 patients have been treated in 2024 with remarkable outcomes.
These patients presented with complex wound infections, including:
🩺 Diabetic foot ulcers
🩺 Pressure ulcers
🩺 Chronic burns
🩺 Skin graft donor site complications
🩺 Autoimmune disease-associated wounds
🩺 LVAD infections
🩺 Cellulitis
🩺 Post-surgical wounds
Ranging from ages 29 to 104, all patients had previously suffered from stalled healing due to chronic biofilm complications. After treatment with the SteriPlas, patients have experienced positive healing outcomes, with many achieving full recovery and others showing ongoing progress toward healing. Importantly, no side effects have been observed during treatments.
This breakthrough highlights the transformative impact of the SteriPlas on chronic infections where other treatments have failed. We're immensely grateful to SG Biomedical and the healthcare professionals who continue to deliver life-changing care to patients in Taiwan.
Together, we’re redefining possibilities in wound care.
Seasons Greetings
As the year comes to a close, we want to take a moment to thank all our valued customers and new connections for your continued trust and support. It's been a pleasure working with you, and we look forward to even greater partnerships in the coming year.
Wishing you a joyful holiday season and a prosperous New Year!
Why Size Matters
Why Size Matters in Cold Plasma Therapy: How SteriPlas Redefines Safety and Efficacy in Wound Treatment
In the fast-evolving world of medical technology, size often seems to shrink in tandem with innovation. Smaller, more portable devices flood the market, promising convenience and versatility, but sometimes critical aspects of functionality can be compromised. Adtec Healthcare’s SteriPlas, a groundbreaking microwave cold plasma device for wound treatment, boldly defies this trend, emphasizing that when it comes to effective and safe medical treatment, bigger truly is better.
SteriPlas: Leading with Power, Safety, and Precision
At a time when competitors are striving for compactness, the SteriPlas stands out with its larger design, which is purposefully engineered to deliver an unmatched level of therapeutic cold plasma. Unlike smaller Cold Plasma devices, the SteriPlas was built to prioritize treatment potency and safety without compromising on effectiveness. But why exactly does size matter for the SteriPlas? The answer lies in its ability to generate a rich, dense cold microwave plasma field that smaller devices simply can’t match.
Delivering Dense Cold Plasma for Optimal Therapeutic Effect
Cold plasma, a unique, non-thermal form of energized gas, has become a significant breakthrough in wound care due to its ability to kill bacteria. However, the efficacy of cold plasma therapy hinges on both the density and consistency of the plasma field, which is directly impacted by the device’s design.
The SteriPlas, with its larger structure, is engineered to generate and sustain a denser, richer microwave argon plasma field. This dense field ensures that cold plasma thoroughly reaches the treatment area, making it more effective at eradicating harmful pathogens and promoting healing. Where smaller devices might struggle to deliver a consistent plasma , the SteriPlas provides a comprehensive, evenly distributed cold plasma field, amplifying its therapeutic benefits.
Prioritizing Safety with No Side Effects
The SteriPlas was also designed with patient safety as a top priority. Despite its larger size and higher plasma density, it remains exceptionally safe for patients, no reported side effects—a critical advantage in any therapeutic device. Smaller devices may sometimes trade off treatment efficacy to meet compact design requirements, but the SteriPlas’s size is integral to its uncompromising safety standards.
Cold plasma therapy’s expanding use in wound treatment has led to a surge in demand for devices that are not only effective but also safe for prolonged and repeated use. SteriPlas’s larger design enables it to incorporate advanced safety protocols that allow it to maintain a rich microwave plasma field without risking tissue damage or other side effects. This design ensures that the SteriPlas can safely treat sensitive areas and deliver results consistently over time.
Setting a New Standard in Cold Plasma Therapy
The SteriPlas represents a thoughtful balance of innovation, efficacy, and patient-centered design, challenging the notion that smaller is always better. While compact devices may offer some portability, the SteriPlas delivers a level of cold plasma density and therapeutic power that smaller devices cannot replicate. This enhanced efficacy, combined with its rigorous safety measures, positions SteriPlas as an ideal choice for clinics and healthcare providers seeking the best outcomes for their patients.
In wound care, where every treatment counts, the SteriPlas’s larger design is not just a feature—it’s a necessity. It’s a testament to Adtec Healthcare’s commitment to ensuring that patients receive the highest standard of care without compromise.
Conclusion
As cold plasma therapy continues to grow in its applications, healthcare professionals face an important decision in choosing devices that prioritize both treatment potency and patient safety. With its robust, thoughtfully engineered design, the SteriPlas offers an unparalleled therapeutic solution that addresses both needs, setting a new benchmark in cold plasma wound therapy. Adtec Healthcare invites clinicians to explore the SteriPlas difference, where bigger means better, safer, and more effective healing.
Handheld and Effective
At Adtec Healthcare Limited, innovation never stands still. Building on the success of our flagship SteriPlas Cold Plasma medical device, we're excited to share a glimpse of the PlasmaTact – our next-generation, compact, handheld argon microwave plasma system.
While not yet on the medical market, the PlasmaTact represents our commitment to pushing the boundaries of plasma technology. Designed for versatility, portability, and new applications, this device showcases the future of plasma-based solutions.
Stay tuned as we continue to explore groundbreaking opportunities with the PlasmaTact – because innovation is at the heart of everything we do.
Day 2 of Medica
Day 2 at MEDICA 2024 – Another Fantastic Day for Adtec Healthcare Limited!
Today marked another successful day at the MEDICA - Leading International Trade Fair. We've had the pleasure of connecting with both new and familiar faces, sharing insights, and discussing how our innovative solutions continue to advance healthcare.
Thank you to everyone who stopped by our booth to learn more about what we do. We're excited to keep building strong relationships and exploring opportunities to make a positive impact in the healthcare industry.
Looking forward to more great conversations in the days ahead! See you tomorrow at Hall 15, Booth A24-3.
Day 1 of Medica
Exciting Day at MEDICA 2024 in Düsseldorf!
What an incredible day connecting with industry leaders, innovators, and healthcare professionals here at the Medica exhibition! We’re thrilled with the positive response to our solutions and the inspiring conversations we’ve had with so many of you.
If you’re attending MEDICA, make sure to stop by our booth, A24-3 in Hall 15! Our team is here, ready to answer your questions and showcase how our SteriPlas Premium Cold Plasma can make a difference in healthcare. Don’t miss out on the chance to see what’s new, chat with us, and be part of this inspiring event!
Looking forward to welcoming even more of you tomorrow!
Adtec joins the MedTech World 2024 this week
We’re thrilled to announce our participation in MedTech World 2024 this week!
Join us as our CEO takes the stage for the panel discussion, "How We Do It: Investors and Entrepreneurs Together." This is a fantastic opportunity to explore innovative collaborations that drive the future of healthcare technology.
Stay tuned for insights and highlights from the event! Let’s connect and shape the future of MedTech together!
https://med-tech.world/news/improving-wound-management-adtec-healthcares-steriplas-technology-explained/
First ever recorded study for CAP on Pediatric Cannula infections
🚨 Exciting News! 🚨
We are thrilled to share a groundbreaking study by Dr. Schlöglhofer, recently published in the Artificial Organs journal from Wiley. This study highlights the remarkable safety and efficacy of using SteriPlas Premium Cold Plasma for managing infections on Berlin Heart EXCOR cannulas.
🌟 This is the first publication to demonstrate the potential of CAP therapy for treating infections and inflammation in pediatric patients with paracorporeal pulsatile VADs.
Key findings show that SteriPlas treatments:
- Do not alter the surface structure of cannulas, as confirmed by SEM micrographs.
- Lead to significant improvements in DESTINE wound staging.
- Drastically reduce bacterial load and inflammatory markers.
- Achieve these results with no observed side effects.
This study marks an exciting step forward in infection management for pediatric VAD patients. To read the full publication, visit: Wiley Library.